Go Pro
→ 'How Much Can I Actually Spend Each Year With $2.5M Saved?' (From SmartAsset) (Ad)tc pixel
NASDAQ:PSNL

Personalis Q2 2026 Earnings Report

Personalis logo
$16.21 +0.04 (+0.27%)
As of 11:46 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Personalis EPS Results

Actual EPS
-$0.30
Consensus EPS
-$0.26
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A

Personalis Revenue Results

Actual Revenue
$22.36 million
Expected Revenue
$16.69 million
Beat/Miss
Beat by +$5.67 million
YoY Revenue Growth
N/A

Personalis Announcement Details

Quarter
Q2 2026
Date
8/4/2026
Time
After Market Closes
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
4:00PM ET

Upcoming Earnings

Personalis' Q3 2026 earnings is estimated for Tuesday, November 3, 2026, based on past reporting schedules, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Powered by Quartr

Earnings Documents

Personalis' Q2 2026 Press ReleasePress Release
(8-K)
Personalis' Q2 2026 Quarterly reportQuarterly report
(10-Q)

Personalis Earnings Headlines

Personalis: The Wrong Side Of The Merger
September 30 at 5:15 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4950916-personalis-the-wrong-side-of-the-merger
《美股主題週報》精準醫療檢測—TEM、ILMN、PSNL
September 29 at 10:02 AM  |  tw.stock.yahoo.comhttps://tw.stock.yahoo.com/news/%E7%BE%8E%E8%82%A1%E4%B8%BB%E9%A1%8C%E9%80%B1%E5%A0%B1-%E7%B2%BE%E6%BA%96%E9%86%AB%E7%99%82%E6%AA%A2%E6%B8%AC-tem-ilmn-psnl-083500961.html
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.tc pixel
October 2 at 1:00 AM  |  SmartAsset (Ad)
Personalis, Inc. (NASDAQ:PSNL) Stock Has Average Price Target of $14.54
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31053956
Personalis (NASDAQ:PSNL) SVP Sells $33,542.96 in Stock
September 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31048917
Personalis (NASDAQ:PSNL) CFO Sells $47,540.82 in Stock
September 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31048915
See More Personalis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Personalis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Personalis and other key companies, straight to your email.

About Personalis

Personalis (NASDAQ:PSNL) is a genomics company focused on precision oncology and advanced genetic testing. The company develops and commercializes molecular diagnostic products designed to help identify cancer-related genomic changes, monitor disease progression and support treatment decisions.

Its product portfolio includes the NeXT platform, which is used to analyze tumor and blood samples. Offerings have included tissue-based profiling, liquid biopsy testing and personalized minimal residual disease monitoring intended to detect small amounts of cancer remaining after treatment or to identify signs of recurrence. Personalis also provides genomic analysis and testing services for biopharmaceutical companies developing cancer therapies and conducting clinical trials.

Founded in 2011 and headquartered in Fremont, California, Personalis initially provided large-scale genomic sequencing and analysis services before focusing more heavily on oncology. The company serves pharmaceutical and biotechnology customers, healthcare organizations and research partners, with testing and genomic services available through collaborations and clinical programs in the United States and other markets.

View Personalis Profile
Earnings Tools